Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes

Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies

(2018) Gianfranco Mattia et al.   Cell Death & Disease

Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells

(2017) Artur Beberok et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells

(2017) Yuzu Zhao et al.   Cell Death & Disease

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

(2016) Nabanita Mukherjee et al.   Oncotarget

Amelanotic melanoma in the vicinity of acquired melanocytic nevi and not arising from agminated melanocytic nevi: Masquerading as pyogenic granuloma

(2016) AngooriGnaneshwar Rao et al.   INDIAN JOURNAL OF DERMATOLOGY

BH3-only proteins - possible proapoptotic triggers for melanoma therapy

(2014) Michael Plötz et al.   EXPERIMENTAL DERMATOLOGY

Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy

(2014) Nethia Mohana-Kumaran et al.   Pigment Cell & Melanoma Research

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas

(2014) Nancy E. Thomas et al.   JAMA Dermatology

Glutathione depletion in survival and apoptotic pathways

(2014) Milena De Nicola et al.   Frontiers in Pharmacology

Crosstalk between apoptosis, necrosis and autophagy

(2013) Vassiliki Nikoletopoulou et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Evaluation and critical assessment of putative MCL-1 inhibitors

(2013) S Varadarajan et al.   CELL DEATH AND DIFFERENTIATION

Molecular biology of normal melanocytes and melanoma cells

(2013) Bizhan Bandarchi et al.   JOURNAL OF CLINICAL PATHOLOGY

BH3 Mimetics: Status of the Field and New Developments

(2013) C. Billard   MOLECULAR CANCER THERAPEUTICS

OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis

(2013) David Wroblewski et al.   PLoS One

Glutathione and modulation of cell apoptosis

(2012) Magdalena L. Circu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The Secret of MIM: A Novel, MCL-1-Specific Small Molecule

(2012) Joshua A. Kritzer   CHEMISTRY & BIOLOGY

A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival

(2012) Nicole A. Cohen et al.   CHEMISTRY & BIOLOGY

Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1

(2012) Daniela Senft et al.   PLoS One

The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy

(2011) P N Kelly et al.   CELL DEATH AND DIFFERENTIATION

Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737

(2011) K. M. Lucas et al.   CLINICAL CANCER RESEARCH

Targeting Mcl-1 for the therapy of cancer

(2011) Bridget A Quinn et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

ABT-737 synergizes with Bortezomib to kill melanoma cells

(2011) S. N. Reuland et al.   Biology Open

Glutathione in Cancer Cell Death

(2011) Angel L. Ortega et al.   Cancers

Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis

(2009) K. Boisvert-Adamo et al.   MOLECULAR CANCER RESEARCH